Spots Global Cancer Trial Database for stage iv nasopharyngeal carcinoma ajcc v8

Every month we try and update this database with for stage iv nasopharyngeal carcinoma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer	NCT06029270	Metastatic Naso... Recurrent Nasop... Stage IV Nasoph...	Biospecimen Col... Bone Scan Carboplatin Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nivolumab Positron Emissi... Relatlimab	18 Years -	National Cancer Institute (NCI)
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer	NCT06029270	Metastatic Naso... Recurrent Nasop... Stage IV Nasoph...	Biospecimen Col... Bone Scan Carboplatin Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nivolumab Positron Emissi... Relatlimab	18 Years -	National Cancer Institute (NCI)
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer	NCT05904080	Nasopharyngeal ... Stage IV Nasoph...	Biospecimen Col... Cabozantinib S-... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC)	NCT06064097	Stage II Nasoph... Stage III Nasop... Stage IV Nasoph...	Biopsy Biospecimen Col... Chest Radiograp... Cisplatin Computed Tomogr... Echocardiograph... Electronic Heal... Fluciclovine F1... Gemcitabine Magnetic Resona... Multigated Acqu... Nivolumab Positron Emissi... Quality-of-Life... Questionnaire A... Radiation Thera... X-Ray Imaging	- 21 Years	National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer	NCT04458909	Metastatic Naso... Metastatic Naso... Metastatic Naso... Metastatic Naso... Nasopharyngeal ... Recurrent Nasop... Recurrent Nasop... Recurrent Nasop... Stage IV Nasoph... Stage IVA Nasop... Stage IVB Nasop...	Carboplatin Cisplatin Gemcitabine Nivolumab Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer	NCT03010150	Carcinoma of Un... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Head... Metastatic Mali... Pathologic Stag... Pathologic Stag... Pathologic Stag... Stage I Hypopha... Stage I Nasopha... Stage II Hypoph... Stage II Laryng... Stage II Nasoph... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Nasop... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Nasoph... Stage IV Oropha... Stage IVA Hypop... Stage IVA Laryn... Stage IVA Nasop... Stage IVA Oroph... Stage IVB Hypop... Stage IVB Laryn... Stage IVB Nasop... Stage IVB Oroph...	Biospecimen Col... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer	NCT05904080	Nasopharyngeal ... Stage IV Nasoph...	Biospecimen Col... Cabozantinib S-... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers	NCT05063552	Clinical Stage ... Metastatic Head... Metastatic Hypo... Metastatic Lary... Metastatic Lip ... Metastatic Nasa... Metastatic Naso... Metastatic Phar... Metastatic Sino... Recurrent Head ... Recurrent Hypop... Recurrent Laryn... Recurrent Lip a... Recurrent Nasop... Recurrent Phary... Recurrent Sinon... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Nasoph... Stage IV Oropha... Stage IV Sinona...	Atezolizumab Bevacizumab Biospecimen Col... Carboplatin Cetuximab Cisplatin Computed Tomogr... Docetaxel Echocardiograph... Magnetic Resona... Positron Emissi...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: